A resolution expressing support for the designation of September 2024 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.
Latest Action
Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S6638-6639; text: 9/25/2024 CR S6450-6451)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This Senate resolution (S.Res. 861) expresses support for designating September 2024 as "Sickle Cell Disease Awareness Month." The resolution aims to promote education across U.S. communities about sickle cell disease, emphasizing the importance of research, early detection, effective treatments, and preventative care programs related to sickle cell disease and its complications. The resolution was agreed to in the Senate by unanimous consent without amendment, indicating broad support. However, the resolution has a status of Failed / Expired, meaning it did not become a permanent or binding measure.
S.Res. 861 is a non-binding Senate resolution supporting awareness efforts for sickle cell disease in September 2024, highlighting the need for education and medical advancements, but it did not advance into law.
- Designates September 2024 as Sickle Cell Disease Awareness Month to increase public education.
- Focuses on raising awareness about research, early detection, treatment, and prevention of sickle cell disease and related complications.
- Passed the Senate by unanimous consent without amendments but ultimately failed or expired without becoming law.
['Individuals living with sickle cell disease and their families', 'Healthcare providers and researchers focused on sickle cell disease', 'Public health organizations and advocacy groups promoting awareness and education']
['As a non-binding resolution, it does not allocate funding or create enforceable programs, limiting direct impact.', 'Lack of detailed implementation mechanisms or oversight provisions to ensure follow-through on awareness or research goals.', "The resolution's failure or expiration means no formal recognition or mandated activities occurred."]
The resolution was introduced and passed in the Senate during the 118th Congress, reflecting a common legislative practice of designating awareness months to highlight health issues. It passed by unanimous consent, indicating bipartisan agreement on the importance of sickle cell disease awareness. However, as a simple resolution, it does not have the force of law and did not progress further, as indicated by its failed or expired status.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public and community awareness could lead to greater advocacy and potential future funding for sickle cell disease research and treatment.', 'Healthcare providers may be encouraged to prioritize early detection and preventative care efforts during the designated awareness month.', 'Nonprofit and advocacy organizations might leverage the awareness month to enhance outreach and education campaigns.']
The resolution's non-binding nature and lack of funding or enforcement mechanisms limit its direct impact. Transparency is constrained by the absence of full bill text and detailed provisions. Monitoring future legislative or funding actions related to sickle cell disease would be necessary to assess substantive government response beyond symbolic recognition.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.